Taille et prévisions du marché de l’ibuprofène intraveineux (2021-2031), part mondiale et régionale, tendances et analyse des opportunités de croissance

  • Report Code : TIPRE00021690
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

INTRODUCTION SUR LE MARCHÉ L'ibuprofène intraveineux est une forme de dosage parentéral ayant une action anti-inflammatoire qui protège des agents infectieux. Il est utilisé pour réduire ou traiter la fièvre, la douleur, l’inflammation, etc. La voie IV d’administration de l’ibuprofène a un délai d’action plus rapide que les autres voies. Il est utilisé pour la douleur aiguë et la gestion postopératoire. Il inhibe la fonction des enzymes COX-1 et COX-2, responsables du contrôle de la synthèse des prostaglandines. DYNAMIQUE DU MARCHÉ Les principaux facteurs qui déterminent sa croissance sur le marché de l'ibuprofène intraveineux sont le résultat rapide, l'administration ciblée de médicaments et une meilleure gestion de la douleur avec une moindre dépendance aux analgésiques opioïdes. En outre, l’augmentation des maladies telles que la polyarthrite rhumatoïde, le cancer, l’arthrose et les maux de tête ainsi que la sensibilisation croissante aux injections rapides pour soulager la douleur devraient favoriser la croissance du marché. De plus, les progrès technologiques et l’augmentation des investissements dans les activités de recherche et développement stimuleront la croissance du marché. Cependant, les effets secondaires associés à l’ibuprofène IV et la longueur du processus d’approbation peuvent entraver le développement du marché de l’ibuprofène IV. ÉTENDUE DU MARCHÉ L'« Analyse du marché de l'ibuprofène intraveineux jusqu'en 2031 » est une étude spécialisée et approfondie du secteur de la santé avec un accent particulier sur l'analyse des tendances du marché mondial. Le rapport vise à fournir un aperçu du marché de l’ibuprofène intraveineux avec une segmentation détaillée du marché par type et par application. Le marché de l’ibuprofène intraveineux devrait connaître une forte croissance au cours de la période de prévision. Le rapport fournit des statistiques clés sur l’état du marché des principaux acteurs du marché de l’ibuprofène intraveineux et présente les principales tendances et opportunités sur le marché. SEGMENTATION DU MARCHÉ Le marché de l'ibuprofène intraveineux est segmenté en fonction du type et de l'application. Sur la base du type, le marché est segmenté en douleur, inflammation et fièvre. Sur la base des applications, le marché est segmenté en pédiatrie, adultes et autres. Le rapport fournit un aperçu détaillé du secteur, comprenant des informations à la fois qualitatives et quantitatives. Il fournit un aperçu et des prévisions du marché de l’ibuprofène intraveineux en fonction de divers segments. Il fournit également la taille du marché et des estimations prévisionnelles de 2021 à 2031 pour cinq grandes régions, à savoir : Amérique du Nord, Europe, Asie-Pacifique (APAC), Moyen-Orient et Afrique (MEA) et Amérique du Sud et centrale. Le marché de l’ibuprofène intraveineux de chaque région est ensuite sous-segmenté par pays et segments respectifs. Le rapport couvre l'analyse et les prévisions de 18 pays dans le monde ainsi que les tendances actuelles et les opportunités prévalant dans la région. Le rapport analyse les facteurs affectant le marché de l’ibuprofène intraveineux du côté de la demande et de l’offre et évalue en outre la dynamique du marché affectant le marché au cours de la période de prévision, c’est-à-dire les moteurs, les contraintes, les opportunités et les tendances futures. Le rapport fournit également une analyse PEST exhaustive pour les cinq régions, à savoir : Amérique du Nord, Europe, APAC, MEA et Amérique du Sud et centrale après avoir évalué les facteurs politiques, économiques, sociaux et technologiques affectant le marché de l’ibuprofène intraveineux dans ces régions. ACTEURS DU MARCHÉ Le rapport couvre les développements clés du marché de l’ibuprofène intraveineux en tant que stratégies de croissance organique et inorganique. Diverses entreprises se concentrent sur des stratégies de croissance organique telles que les lancements de produits, les approbations de produits et d'autres telles que les brevets et les événements. Les stratégies de croissance inorganique observées sur le marché étaient des acquisitions, des partenariats et des collaborations. Ces activités ont ouvert la voie à l’expansion des activités et de la clientèle des acteurs du marché. Les acteurs du marché de l’ibuprofène intraveineux devraient avoir des opportunités de croissance lucratives à l’avenir avec la demande croissante d’ibuprofène intraveineux sur le marché mondial. Vous trouverez ci-dessous la liste des quelques entreprises engagées sur le marché de l’ibuprofène intraveineux. Le rapport comprend également les profils des principaux acteurs du marché de l’ibuprofène intraveineux ainsi que leur analyse SWOT et leurs stratégies de marché. En outre, le rapport se concentre sur les principaux acteurs de l’industrie avec des informations telles que les profils d’entreprise, les composants et services proposés, les informations financières des 3 dernières années et les développements clés des cinq dernières années.
    • Teligent • Harbin Gloria Pharmaceuticals • Cumberland Pharmaceuticals Inc • Soho Industri Pharmasi • Al Nabeel International Ltd • CSL Limited • Sandor Medicaids • Grifols • Germin MED
L'équipe de recherche et d'analyse dédiée d'Insight Partner est composée de professionnels expérimentés possédant une expertise statistique avancée et propose diverses options de personnalisation dans l'étude existante.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR in Intravenous Ibuprofen Market?

The market is expected to register a CAGR of 6.5% during 2021–2031.

What are driving factors impacting the Intravenous Ibuprofen Market?

The industry's driving factors include increased hospitalization rates and pain management without opioids.

What are the future trends of Intravenous Ibuprofen Market ?

Some of the key trends include non-opioid pain management, expansion of ambulatory care, and advanced technology of drug delivery systems.

Which are leading players in Intravenous Ibuprofen Market?

Market leaders in the market for intravenous ibuprofen are Teligent, Harbin Gloria Pharmaceuticals, Cumberland Pharmaceuticals Inc, Soho Industri Pharmasi, Al Nabeel International Ltd, CSL Limited, Sandor Medicaids, Grifols, Germin MED.,

What are the deliverable formats of the Intravenous Ibuprofen Market?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Teligent
2. Harbin Gloria Pharmaceuticals
3. Cumberland Pharmaceuticals Inc
4. Soho Industri Pharmasi
5. Al Nabeel International Ltd
6. CSL Limited
7. Sandor Medicaids
8. Grifols
9. Germin MED

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.